|
|
1H NMR STUDIES OF NON-HODGKINS LYMPHOMA
|
2R01CA101700-05A2
|
$357,353
|
$357,353
|
GLICKSON, JERRY
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
A Comprehensive Investigation of Viral-induced Lymphomagenesis
|
5R01CA121180-04
|
$268,080
|
$268,080
|
FISHER, SUSAN
|
UNIVERSITY OF ROCHESTER
|
|
|
A Genome-Wide Association Study of Non-Hodgkin Lymphoma
|
5R01CA122663-04
|
$513,360
|
$513,360
|
Skibola, Christine
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
|
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1
|
ZIA BC 011064
|
$247,815
|
$49,563
|
Mock, Beverly
|
CCR (NCI)
|
|
|
A novel enzymatic activity of WSTF and its role in tumorigenesis
|
1K99CA131560-01A1
|
$125,651
|
$125,651
|
XIAO, ZHUO
|
ROCKEFELLER UNIVERSITY
|
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$327,420
|
$98,226
|
Tosato, Giovanna
|
CCR (NCI)
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S1
|
$114,606
|
$6,842
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S3
|
$100,000
|
$5,970
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-34
|
$7,326,647
|
$437,401
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Academic Training in Medical Oncology
|
2T32CA009297-26A2
|
$311,497
|
$31,150
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Activation of BCL-2 in Hematologic Malignancies
|
5R01CA056764-15
|
$290,500
|
$290,500
|
BOXER, LINDA
|
PALO ALTO INSTITUTE FOR RES & EDU, INC.
|
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$279,762
|
$41,964
|
Aplan, Peter
|
CCR (NCI)
|
|
|
ADD ARTICLE H.49., EXCHANGE OF CONFIDENTIAL INFORMATION AND RESEARCH MATERIALS
|
N01CO800001-012
|
$231,187,932
|
$5,540,000
|
ARTHUR, LARRY
|
SAIC-FREDERICK INC:1107088
|
|
|
AIDS and Cancer Specimen Resource Central Office and Data Coordinating Center
|
5U01CA096230-07
|
$739,770
|
$170,147
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
AIDS Associated Lymphoproliferative Disorders
|
5R37CA037295-26
|
$402,500
|
$402,500
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
AIDS Malignancy Clinical Trials Consortium
|
3U01CA121947-03S4
|
$3,605,692
|
$829,309
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
An Exercise Intervention to Improve Health in Postmenopausal Cancer Survivors
|
5R01CA122658-03
|
$99,585
|
$24,896
|
KNOBF, M
|
YALE UNIVERSITY
|
|
|
Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression
|
5R01CA130752-02
|
$309,175
|
$309,175
|
FLEMINGTON, ERIK
|
TULANE UNIVERSITY OF LOUISIANA
|
|
|
Analysis of the p53 in vivo using a unique mouse model
|
5R01CA100193-07
|
$344,459
|
$34,446
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Anatomic Pathology Residency Program
|
ZIE BC 010684
|
$1,339,887
|
$133,989
|
Jaffe, Elaine
|
CCR (NCI)
|
|
|
Animal Model and Genotyping Core Support Facility
|
ZIC BC 011047
|
$943,811
|
$188,762
|
DuBois, Wendy
|
CCR (NCI)
|
|
|
Annual Primary CNS Lymphoma Collaborative Group Meeting
|
5R13CA124293-04
|
$5,000
|
$5,000
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies
|
ZIA BC 010647
|
$293,868
|
$146,934
|
Rader, Christoph
|
CCR (NCI)
|
|
|
Antibody-based therapeutics and vaccines against AIDS
|
ZIA BC 011155
|
$287,030
|
$143,515
|
Dimitrov, Dimiter
|
CCR (NCI)
|
|
|
Antibody-mediated Gene Therapy for the Treatment of Cancer
|
1K01CA138559-01A1
|
$136,347
|
$136,347
|
Daniels, Tracy
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Antigen Discovery and Development of Tumor-Specific Lymphoma Immunotherapy
|
5K23CA123149-03
|
$136,080
|
$136,080
|
Neelapu, Sattva
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Arginine Availability, Modulated by MDSC, Regulates T Cell Function in Cancer
|
2R01CA082689-09
|
$249,940
|
$62,485
|
OCHOA, AUGUSTO
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
|
ATBC Study
|
ZIA CP010195-03031
|
$804,186
|
$80,419
|
Albanes
|
DCEG (NCI)
|
|
|
Atlanta Regional Community Clinical Oncology Program (ARCCOP)
|
5U10CA045450-23
|
$709,605
|
$7,096
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
|
B Cell Lymphoma Therapy
|
5R01CA121039-03
|
$244,245
|
$244,245
|
CHOI, YONG
|
OCHSNER CLINIC FOUNDATION
|
|
|
Basis for Lymphomagenesis in Akt2 Transgenic Mice
|
2R01CA077429-10A2
|
$418,237
|
$418,237
|
TESTA, JOSEPH
|
FOX CHASE CANCER CENTER
|
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
$5,212
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S1
|
$117,279
|
$12,901
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S2
|
$245,600
|
$27,016
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-03
|
$1,515,000
|
$166,650
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-08
|
$749,588
|
$7,496
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
|
BIDMC Research Training Grant in Cancer Radiology
|
5T32CA059367-15
|
$99,433
|
$19,887
|
CLOUSE, MELVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$728,095
|
$72,809
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Biochemical Basis of T Cell Activation
|
ZIA BC 010304
|
$1,107,977
|
$553,988
|
Samelson, Lawrence
|
CCR (NCI)
|
|
|
Biologic Therapy for B-cell non-Hodgkin's Lymphoma
|
5R01CA092104-06
|
$258,741
|
$258,741
|
ANSELL, STEPHEN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
Biomonitoring of Organochlorines
|
ZIA CP010121-02037
|
$74,400
|
$74,400
|
Baris
|
DCEG (NCI)
|
|
|
Bone Marrow Grafting for Leukemia and Lymphoma
|
5P01CA049605-21
|
$3,525,298
|
$1,551,131
|
NEGRIN, ROBERT
|
STANFORD UNIVERSITY
|
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-34
|
$3,012,562
|
$301,256
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Branch Clinical Research Core
|
ZID BC 010963
|
$1,239,800
|
$743,880
|
Gress, Ronald
|
CCR (NCI)
|
|
|
Breast implant follow-up study
|
ZIA CP010128-01220
|
$16,802
|
$840
|
Brinton
|
DCEG (NCI)
|
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,313,626
|
$65,681
|
Restifo, Nicholas
|
CCR (NCI)
|
|
|
c-Myc Expression during Lymphomagenesis
|
3R01CA068328-12S1
|
$50,292
|
$25,146
|
RUDDELL, M
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
c-Myc-regulated microRNAs in normal and pathologic cellular physiology
|
5R01CA120185-03
|
$309,168
|
$204,051
|
MENDELL, JOSHUA
|
JOHNS HOPKINS UNIVERSITY
|
|
|
C-N-, and L-MYC Effects on Hematopoietic Cells
|
7R01CA078259-10
|
$244,204
|
$244,204
|
Prochownik, Edward
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
CALGB Member Site: University of California - San Francisco
|
1U10CA138561-01
|
$107,184
|
$4,287
|
RYAN, CHARLES
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Total relevant funding to Non Hodgkins Lymphoma for this search: $130,883,333
|
